AcrIF11是一种强大的CRISPR特异性ADP-ribosyltransferase,由菌体和等离子体编码
Daphne F Chen1, Leah T Roe2, Yuping Li3
1Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA.
bioRxiv : the preprint server for biology
|September 10, 2024
概括
像AcrIF11这样的酶性抗CRISPR (Acr) 蛋白质强烈抑制了细菌的CRISPR-Cas系统. 这项研究揭示了AcrIF11的存在.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 菌体使用抗CRISPR (Acr) 蛋白来逃避细菌CRISPR-Cas免疫系统,从而使复制成为可能.
- 大多数特征化的Acrs是固态测量抑制剂;酶性Acrs的特性,如AcrIF11,仍然不太了解.
- AcrIF11是一种ADP-ribosyltransferase (ART),其向的是I-F型CRISPR-Cas系统.
研究的目的:
- 为了研究酶抗CRISPR蛋白AcrIF11.11的功效,特异性和可逆性.
- 为了阐明AcrIF11抑制I-F型CRISPR-Cas系统的机制.
- 为了比较酶性Acrs与细菌防御逃避中的固体测量抑制剂的疗效.
主要方法:
- 核磁共振 (NMR) 光谱法以确定AcrIF11同类的结构并确定辅因子结合.
- 在体内实验中模拟菌体复制和在高准压力下溶原稳定性的实验.
- 生物化学试验以评估ADP-ribosylation特异性和宏酶对Csy1修饰的影响.
主要成果:
- 核磁共振分析揭示了结构特征与NAD结合一致的NAD结合在一个AcrIF11同类.
- AcrIF11证明了I-F型CRISPR-Cas系统的强大和强大的抑制作用,其表现优于静态测量抑制剂.
- 具体来说,AcrIF11是ADP-ribosylated Csy1,这种修饰是巨酶可以逆转的.
- 该研究证实了AcrIF11在体内具有强大和特异性的抑制作用,将体内酶活性与生物结果联系起来.
结论:
- AcrIF11作为I-F型CRISPR-Cas系统的强大和特定的酶抑制剂.
- 由于AcrIF11的ADP-ribosylation活性是可逆的,因此具有优势和潜在的限制.
- 了解像AcrIF11这样的酶性Acrs,可以了解菌体和细菌之间的共同进化动态.
更多相关视频
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
187
09:29Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
Published on: February 28, 2025
663
相关概念视频
CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
CRISPR
49.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.8K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
